Showing results (551-560 of 598) with videos related to

Sort By:
Pageof 60
Science Advances|July 16, 2025
Impaired mitochondrial metabolism is a critical cancer vulnerability for MYC inhibitorsWilliam Yang, Qianyu Guo, Songhua Quan, et al.
Stroke|June 23, 2020
Pivotal Trial of the Neuroform Atlas Stent for Treatment of Anterior Circulation Aneurysms: One-Year OutcomesOsama O Zaidat, Ricardo A Hanel, Eric A Sauvageau, et al.
Neurosurgery|April 7, 2021
Neuroform Atlas Stent for Treatment of Middle Cerebral Artery Aneurysms: 1-Year Outcomes From Neuroform Atlas Stent Pivotal TrialRicardo A Hanel, Nam Yoon, Eric Sauvageau, et al.
Stroke (Hoboken, N.J.)|January 26, 2026
Y-Stent-Assisted Coiling of Wide-Necked Intracranial Aneurysms With the Neuroform Atlas Stent SystemAshutosh P Jadhav, Shashvat M Desai, Tudor G Jovin, et al.
The Journal of Prevention of Alzheimer'S Disease|September 29, 2021
Immunotherapy for Alzheimer's Disease: Current Scenario and Future PerspectivesM B Usman, S Bhardwaj, S Roychoudhury, et al.
AJNR. American Journal of Neuroradiology|April 23, 2021
Cerebral Venous Thrombosis in COVID-19: A New York Metropolitan Cohort StudyF Al-Mufti, K Amuluru, R Sahni, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2026
A bivalent lysine-acetylated small-molecule binding site in MYCDikshat G Gupta, Mihai I Truica, Adam W T Steffeck, et al.
ESMO Open|January 20, 2026
Pathological complete response with neoadjuvant pembrolizumab and chemotherapy in non-metastatic triple-negative inflammatory breast cancerF Lynce, C Valenza, S M Niman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 12, 2022
Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer in CheckMate 227Julie R Brahmer, Jong-Seok Lee, Tudor-Eliade Ciuleanu, et al.
The British Journal of Dermatology|February 13, 2018
A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapyC A Morton, R Dominicus, P Radny, et al.
Pageof 60